Eric Lefkofsky, a Philanthropic Entrepreneur

Eric Lefkofsky is a wealthy American businessman with a net worth estimated to be around $1.7 billion. He extensively uses technology to give back to the community and help people who desperately need help. He co-founded Tempus a Lab that uses technology and data to make cancer treatment better and modernize its treatment.Eric uses his social media accounts to educate his friends and followers about cancer, raise funds for cancer patients and promote cancer awareness. His Twitter account is mainly focused on the technology and its impact on the health sector.Lefkofsky founded Lefkofsky Family Foundation a charitable organization that he uses as a platform to better the lives of those in need. The foundation also supports educational organizations, scientific centers, and other charitable organizations.

Eric focused on individuals who want to be a successful entrepreneurs in his book “Accelerated Disruption.” The book is ideal for people with ideas which are not yet implemented; it tells you how to change ideas to enterprises.Eric Lefkofsky was born in 1969 and raised up by his parents in Southfield, Michigan. He later graduated from the University of Michigan with bachelor’s degree in law. He has been working to better his entrepreneurship skills and using technology to find a solution to cancer treatment. Eric has also been actively involved in working with charitable organizations targeting education, health, technology, and human rights.

Some of his philanthropy includes a program dubbed Moneythink which he uses to provide financial mentorship to children in urban areas. He also assists the community through human rights organizations like Planned Parenthood of Illinois, health agencies like Medical Mission for Children among others. He is also a board member of Lurie’s Children Hospital Chicago, Museum of Science and Technology, and the Art Institute of Chicago. He uses these board membership positions to better the lives of people in his community.

Dr. Clay Siegall CEO Of Seattle Genetics

Dr. Clay Siegall is the CEO and president of the Bothell, Washington based biotechnology company Seattle Genetics. The company is at the forefront of cancer research and has provided physicians all over the world with effective treatments to help them improve life for cancer patients. Dr. Siegall has a BS in Zoology from the University of Maryland and earned a PhD in genetics from George Washington University. A scientist by training, Dr. Siegall founded Seattle Genetics in 1998 as a company focused on using rigorous research, scientific innovation and visionary drug development practices.


Dr. Siegall does more than just help to guide Seattle Genetics in the development of antibody drug conjugates to be used to treat cancer, he is also the company’s chief fundraiser. He has led capital-raising activities from public and private sources that have secured over $675 million. Dr. Siegall has also generated over $300 million for the company through multiple strategic licenses he has arranged for the company’s proprietary ADC technology. Dr. Siegall has license agreements with AbbVie, Genentech, Pfizer and GlaxoSmithKline. Seattle Genetics also has 20 ADCs currently in clinical development internal and collaborator programs that use the company’s technology.


As part of his commitment to cancer research Dr. Siegall shares his time and expertise with numerous companies developing new treatment methods. Since 2006 he’s been director of the board of Alder Biopharmaceuticals, Mirna Therapeutics and Ultragenyx Pharmaceutical. Through this role he has helped those companies with fund raising and work on targeted cancer therapies. All of that is part of the legacy of this visionary cancer researcher. He has also worked with Bristol-Myers Squibb Pharmaceutical Research Institute, the National Institutes of Health as well as the National Cancer Institute.


Dr. Siegall has received many awards and accolades for his work in cancer research and treatment. In 2013 he was voted Alumnus of the Year for Computer, Math and Natural Sciences by the University of Maryland. In 2012 he was selected as Entrepreneur of the Year Pacific Northwest by Ernst & Young. Dr. Siegall’s writings have appeared in over 70 publications. He also holds 15 patents.